Title : Metformin and cancer: An existing drug for cancer prevention and therapy.

Pub. Date : 2018 Jan

PMID : 29422962






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Studies have demonstrated that reducing insulin and insulin-like growth factor levels in the peripheral blood circulation may lead to the inhibition of phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin (mTOR) signaling or activation of AMP-activated protein kinase, which inhibits mTOR signaling, a process that may be associated with the antitumor effect of metformin. Metformin AKT serine/threonine kinase 1 Homo sapiens